中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 1
Jan.  2019
Turn off MathJax
Article Contents

Clinical effect of human serum albumin versus artificial colloidal fluid in patients with cirrhotic ascites undergoing drainage:A Meta-analysis

DOI: 10.3969/j.issn.1001-5256.2019.01.015
Research funding:

 

  • Received Date: 2018-08-29
  • Published Date: 2019-01-20
  • Objective To investigate the clinical effect of infusion of albumin versus artificial colloidal fluid after ascites drainage in patients with liver cirrhosis and ascites.Methods Cochrane Library (from 1993 to February 2018) PubMed (from 1966 to February 2018) , Embase (from 1990 to February 2018) , Chinese Scientific Journal Full-Text Database (from 1994 to February 2018) , CBM (from 1978 to February 2018) , China Science and Technology Journal Database (from 1989 to February 2018) , Chinese Medical Association Digital Periodical Database (from 1997 to February 2018) , and related periodicals and conference proceedings were searched for randomized controlled trials (RCTs) on infusion of albumin and artificial colloidal fluid after ascites drainage in patients with liver cirrhosis and ascites.The modified JADAD method and Cochrane systematic review were used for data extraction and literature quality assessment, and a statistical analysis was performed.RevMan 5.3 was used for the Meta-analysis.Results A total of 7 RCTs with 696 patients were included, with 299 patients in the human serum albumin group and 397 in the artificial colloidal fluid group.The human serum albumin group had a significantly lower incidence rate of hyponatremia than the artificial colloidal fluid group (11.04%vs 20.4%, risk ratio[RR]=0.58, 95%confidence interval[CI]:0.40-0.84, P=0.004) .There were no significant differences between the two groups in the incidence rates of kidney injury (7.02%vs 7.81%, RR=0.93, 95%CI:0.53-1.65, P=0.82) , hepatic encephalopathy (6.77%vs 7.45%, RR=0.87, 95%CI:0.48-1.55, P=0.63) , gastrointestinal bleeding (3.91%vs 3.65%, RR=0.97, 95%CI:0.43-2.22, P=0.95) , abdominal infection (5.22%vs 4.56%, RR=1.07, 95%CI:0.52-2.18, P=0.86) , and hospital death (12.78%vs 14.59%, RR=0.70, 95%CI:0.47-1.02, P=0.06) .ConclusionHuman albumin has an advantage over artificial colloidal fluid in reducing hyponatremia after ascites drainage in patients with cirrhotic ascites.

     

  • loading
  • [1]MOORE KP, AITHAL GP.Guidelines on the management of ascites in cirrhosis[J].Gut, 2006, 55 (Suppl 6) :1-12.
    [2]RUNYON BA.Management of adult patients with ascites due to cirrhosis:An update[J].Hepatology, 2009, 49 (6) :2087-2107.
    [3]European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J].J Hepatol, 2010, 53 (3) :397-417.
    [4]D'AMICO G, GARCIA-TSAO G, PAGLIARO L.Natural history and prognostic indicators of survival in cirrhosis:A systematic review of 118 studies[J].J Hepatol, 2006, 44 (1) :217-231.
    [5]CHOLONGITAS E, PAPATHEODORIDIS GV, MANESIS EK, et al.Spontaneous bacterial peritonitis in cirrhotic patients:Is prophylactic propranolol therapy beneficial?[J].J Gastroenterol Hepatol, 2006, 21 (3) :581-587.
    [6]JADAD AR, MOORE RA, CARROLL D, et al.Assessing the quality of reports of randomized clinical trials:Is blinding necessary?[J].Control Clin Trials, 1996, 17 (1) :1-12.
    [7]HERNNDEZ PREZ RE, AGUILAR RAMREZ JR, HERNNDEZLPEZ JM, et al.Massive paracentesis and administration of dextran 70 vs albumin in cirrhotic patients with tense ascites[J].Rev Gastroenterol Mex, 1995, 60 (1) :22-26.
    [8]BERTRN X, FERNNDEZ-BAARES F, PLANAS R, et al.Impact on the energetic-proteic nutritional status of total paracentesis combined with infusion of albumin or dextran-70 in the therapy of tension ascites in liver cirrhosis[J].Rev Esp Enferm Dig, 1991, 79 (5) :320-323.
    [9]MOREAU R, VALLA DC, DURAND-ZALESKI I, et al.Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid:A randomised controlled pilot trial[J].Liver International, 2006, 26 (1) :46-54.
    [10]ALTMAN C, BERNARD B, ROULOT D, et al.Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis[J].Eur J Gastroenterol Hepatol, 1998, 10 (1) :5-10.
    [11]GINS A, FERNNDEZ-ESPARRACH G, MONESCILLO A, et al.Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis[J].Gastroenterology, 1996, 111 (4) :1002-1010.
    [12]SALERNO F, BADALAMENTI S, LORENZANO E, et al.Randomized comparative study of hemaccel vs.albumin infusion after total paracentesis in cirrhotic patients with refractory ascites[J].Hepatology, 1991, 13 (4) :707-713.
    [13]GARCA-COMPEAN D, BLANC P, LARREY D, et al.Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis:A randomized controlled trial[J].Ann Hepatol, 2002, 1 (1) :29-35.
    [14]FASSIO E, TERG R, LANDEIRA G, et al.Paracentesis with Dextran70 vs.aracentesis wit albumin in cirr with tense ascites results of a randomized study[J].J Hepatol, 1992, 14 (2-3) :310-316.
    [15]PLANAS R, GINS P, ARROYO V, et al.Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis[J].Gastroenterology, 1990, 99 (6) :1736-1744.
    [16]XU LL, SU L, WANG C, et al.Therapcutic effects of tolvaptan on patients of cirrhosis, ascites complicated with hyponatremia[J/CD].Chin J Liver Dis:Electr Version, 2018, 10 (2) :87-90. (in Chinese) 徐力力, 苏良, 王晨, 等.托伐普坦治疗伴低钠血症肝硬化腹水患者的疗效[J/CD].中国肝脏病杂志:电子版, 2018, 10 (2) :87-90.
    [17]Chinese Society of Hepatology, Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J].J Clin Hepatol, 2017, 33 (10) :1847-1863. (in Chinese) 中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志, 2017, 33 (10) :1847-1863.
    [18]RUIZ-DEL-ARBOL L, MONESCILLO A, JIMENEZ W, et al.Paracentesis-induced circulatory dysfunction:Mechanism and effect on hepatic hemodynamics in cirrhosis[J].Gastroenterology, 1997, 113 (2) :579-586.
    [19]PREDESCU D, PREDESCU S, MALIK AB.Transport of nitrated albumin across continuous vascular endothelium[J].Proc Natl Acad Sci U S A, 2002, 99 (21) :13932-13937.
    [20]SORT P, NAVASA M, ARROYO V, et al.Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis[J].N Engl JMed, 1999, 341 (6) :403-409.
    [21]WU J, YIN F, LUO GH, et al.Association of hyponatremia with degree of liver injury and complications in patients with decompensated liver cirrhosis[J].J Clin Hepatol, 2017, 33 (2) :277-280. (in Chinese) 武健, 尹芳, 罗贯虹, 等.失代偿期肝硬化患者低钠血症与肝损伤程度及并发症的关系[J].临床肝胆病杂志, 2017, 33 (2) :277-280.
    [22]WANG HQ, LIN Y, YAN Y.Clinical study on the significcance of hyponatremia in patients with cirrhotic ascites[J].J Clin Exp Med, 2017, 16 (22) :2275-2278. (in Chinese) 王慧卿, 林叶, 严艳.肝硬化腹水合并低钠血症的临床研究[J].临床和实验医学杂志, 2017, 16 (22) :2275-2278.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1712) PDF downloads(323) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return